Advisory Committee Policy Allows Members With Financial Conflicts To Vote
This article was originally published in The Tan Sheet
FDA advisory committee participants with personal financial conflicts of interest may fully participate in committee meetings, according to the agency's latest conflict of interest policy
You may also be interested in...
FDA is working on an initiative to bring current advisory committee vacancies from around 30 percent down to 10 percent of its more than 600 spots without backing down from a strict conflict-of-interest policy that many see as contributing to the difficulty in filling the seats
New Nonprescription Drugs Advisory Committee member James Kehrer's expertise on acetaminophen toxicity should make him a key figure at FDA's upcoming meeting on the drug, he says
FDA advisory committees are increasingly relying on temporary members to fill their ranks - a trend that could result in less predictability for drug sponsors at a make-or-break review meeting